Skip to main content
. 2025 Dec 29;19(1):65. doi: 10.3390/ph19010065
2D Two dimensional
3D Three dimensional
ATP Adenosine Triphosphate
BBB Blood–brain barrier
BL-PDT Bioluminescence-Mediated Photodynamic Therapy
BODIPY 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene
CALR Calreticulin
CCR5 Chemokine Receptor Type 5
CCR7 Chemokine Receptor Type 7
CD Cluster of Differentiation
CPPs Cell Penetrating Peptides
CTL Cytotoxic T Lymphocytes
DAMPs Damage-Associated Molecular Patterns
DCs Dendritic Cells
DLI Drug to Light Interval
ECM Extracellular Matrix
EGFR Epidermal Growth Factor Receptor
EPR Enhanced Permeability and Retention
F4BMet 5,10,15,20-tetrakis-[2′,3′,5′,6′-tetrafluoro-4′-methanesulfamoyl)phenyl] bacteriochlorin
FBS Fetal Bovine Serum
FR Folate receptor
GLUTs Glucose Transporter
HCC Hepatocellular Carcinoma
HER2 Human Epidermal Growth Factor Receptor 2
HMGB1 High-Mobility Group Box 1
HSA Human Serum Albumin
HSP70 Heat Shock Protein 70
ICD Immunogenic Cell Death
IDO Indoleamine 2,3-Dioxygenase
NK Natural Killer Cells
NIR Near-Infrared
NIR-II Second Near-Infrared Window (1000–1700 nm)
NIR-IIa Sub-window of NIR-II (1300–1400 nm)
OoC Organ on chip
PA Pyropheophorbide-a
PDT Photodynamic Therapy
PIT Photoimmunotherapy
PpIX Protoporphyrin IX
PS/PSs Photosensitizer/Photosensitizers
RNI Reactive Nitrogen Intermediates
RONS Reactive Oxygen and Nitrogen Species
ROS Reactive Oxygen Species
SBCS Symmetry-Breaking Charge Separation
SELEX Systematic Evolution of Ligands by Exponential Enrichment
TME Tumour Microenvironment